ロード中...
Can we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation?
AIM: Both dose-escalated external beam radiotherapy (DE-EBRT) and androgen deprivation therapy (ADT) improve outcomes in patients with high-risk prostate cancer. However, there is little evidence specifically evaluating DE-EBRT for patients with high-risk prostate cancer receiving ADT, particularly...
保存先:
| 出版年: | Onco Targets Ther |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4869660/ https://ncbi.nlm.nih.gov/pubmed/27274277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S105174 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|